Tetrous, Inc. is a leading medical technology company based in Los Angeles, CA, specializing in the development and production of innovative solutions for rotator cuff repair. Their flagship product, EnFix RC, is a demineralized bone fiber implant designed to simplify the delivery of the product into the interface between the bone and the tendon, revolutionizing the way rotator cuff repairs are performed. With a successful clinical legacy and extensive studies in bone and tendon healing, Tetrous' EnFix RC promotes optimal biologic performance and tissue remodeling, addressing the crucial clinical need for tendon reattachment to the bone.
With a focus on enhancing healing at the tendon-to-bone interface, Tetrous has flipped the script in the field of rotator cuff repair. Their technology, including Bone Textile and FormLok, ensures long and strong fibers that promote cell wicking, adhesion, and proliferation, providing superior results compared to other augmentation products. With a market size of $3 billion in the United States alone, Tetrous is at the forefront of addressing the increasing failure rates of rotator cuff repairs, offering a procedure-specific solution that is minimally disruptive to the rotator cuff workflow.
Generated from the website